Viatris wins FDA approval for first generic of AstraZeneca's Symbicort - Seeking Alpha

Retrieved on: 2022-03-16 03:48:29

Tags for this article:

Click the tags to see associated articles and topics

Viatris wins FDA approval for first generic of AstraZeneca's Symbicort - Seeking Alpha. View article details on hiswai:

Excerpt

Symbicort generated $2.7 billion revenue for AstraZeneca (AZN) in 2021 with a ~2% YoY decline in constant currency terms.

Article found on: seekingalpha.com